BackgroundDuration of untreated psychosis (DUP) is one of the few potentially modifiable
predictors of outcomes of schizophrenia. Long DUP as a predictor of poor short-term …

Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …

Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …

The first psychotic episode is classically viewed as a critical period which management is
important in determining the long-term outcome of the schizophrenia (SCZ). For this reason …

The purpose of this review is to describe research over the past 10 years on the role of
support services in promoting medication adherence in mental health consumers diagnosed …

Background Levels of non-adherence to antipsychotic medication in persons with
schizophrenia in rural African settings have been shown to be comparable to those found in …

Background: In spite of the progress made in the treatment of psychiatric disorders during
the last few decades, nonadherence continues to be a frequent phenomenon, often …

Given the high rates of treatment disengagement and medication nonadherence in
individuals with schizophrenia spectrum disorders and early psychosis, fostering a strong …

Objectives We sought to understand the association of specific aspects of care satisfaction,
such as patients' perceived relationship with their psychiatrist and access to their psychiatrist …

Introduction It has been proposed that theory of mind (ToM) deficits underlying difficulties in
taking the perspective of others may substantially contribute to insight impairment in …